Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 53

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 53
---
 03/24/2017 |
| 10.13

#  |     | Second Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated February 6, 2020.                                                                |     |                           | 10-K |     |             | 001-34375  |     |         | 10.25 |     |             | 03/30/2020 |
| 10.14

#  |     | Third Amendment to The Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated June 6, 2024.                                                                     |     |                           | S-1  |     |             | 333-280061 |     |         | 10.15 |     |             | 06/07/2024 |
| 10.15

#  |     | Form of Notice of Grant of Stock Option under the 2015 New Employee Incentive Plan.                                                                                      |     |                           | S-8  |     |             | 333-210211 |     |         |  99.5 |     |             | 03/15/2016 |
| 10.16

#  |     | Form of Stock Option Agreement under the 2015 New Employee Incentive Plan.                                                                                               |     |                           | S-8  |     |             | 333-210211 |     |         |  99.4 |     |             | 03/15/2016 |
| 10.17

#  |     | Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as amended and restated.                                                                                              |     |                           | 8-K  |     |             | 001-34375  |     |         |  10.1 |     |             | 05/17/2021 |
| 10.18

#  |     | Form of Notice of Grant and Stock Option Agreement under the 2020 Stock Incentive Plan.                                                                                  |     |                           | 10-K |     |             | 001-34375  |     |         | 10.26 |     |             | 02/24/2022 |
II-7

Confidential Treatment Requested by Plus Therapeutics, Inc. Pursuant to 17 C.F.R. Section 200.83

|         |     |                                                                                                                                                                                                                       |     | Incorporated